The initiative aligns with global psycho-oncology standards that advocate routine distress screening as a core quality benchmark in cancer treatment
The results were consistent across both the 10 mg and 40 mg treatment arms
Landmark procedure restores 32-year-old CKD patient’s health, highlighting how public insurance is widening access to advanced renal care
Final approval for progesterone vaginal inserts expands Glenmark’s women’s healthcare portfolio in the US, targeting a market of over $59 million
Divestment marks Redcliffe’s strategic pivot toward preventive and advanced diagnostics; Crysta IVF to continue under existing leadership
Surgeon Yuvaraja operates on a 55-year-old patient at Medical City Hospital Muscat
The acquisition complements Gilead’s existing oncology expertise and development infrastructure
TG4050 harnesses Transgene’s myvac platform and NEC’s AI-powered neoantigen prediction technology to tailor vaccines to each patient’s tumor
Opioid dependence remains a major driver of death and disease worldwide
Subscribe To Our Newsletter & Stay Updated
